Loading...
IDT Australia Limited
IDT.AX•ASX
Healthcare
Drug Manufacturers - Specialty & Generic
A$0.09
A$-0.00(-1.11%)
IDT Australia Limited (IDT.AX) Financial Performance & Statements
Review IDT Australia Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
90.71%
↑ 90.71%
Operating Income Growth
49.38%
↑ 49.38%
Net Income Growth
36.30%
↑ 36.30%
Operating Cash Flow Growth
-21.51%
↓ 21.51%
Operating Margin
-19.86%
↓ 19.86%
Gross Margin
53.29%
↑ 53.29%
Net Profit Margin
-25.58%
↓ 25.58%
ROE
-19.17%
↓ 19.17%
ROIC
-13.88%
↓ 13.88%
IDT Australia Limited (IDT.AX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for IDT Australia Limited stock.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Revenue | $13.23M | $6.93M | $12.11M | $15.99M |
| Cost of Revenue | $6.52M | $10.47M | $9.28M | $11.11M |
| Gross Profit | $6.70M | -$3.53M | $2.82M | $4.88M |
| Gross Profit Ratio | $0.51 | -$0.51 | $0.23 | $0.31 |
| R&D Expenses | $441000.00 | $0.00 | $120000.00 | $131000.00 |
| SG&A Expenses | $9.51M | $6.34M | $4.72M | $4.85M |
| Operating Expenses | $12.44M | $6.24M | $4.70M | $3.91M |
| Total Costs & Expenses | $18.97M | $16.71M | $13.98M | $15.02M |
| Interest Income | $102000.00 | $0.00 | $0.00 | $29000.00 |
| Interest Expense | $119000.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $925000.00 | $1.04M | $1.54M | $1.78M |
| EBITDA | -$5.03M | -$8.85M | -$340000.00 | $2.75M |
| EBITDA Ratio | -$0.38 | -$1.26 | -$0.03 | $0.17 |
| Operating Income | -$4.95M | -$9.78M | -$1.88M | $966000.00 |
| Operating Income Ratio | -$0.37 | -$1.41 | -$0.15 | $0.06 |
| Other Income/Expenses (Net) | -$1.13M | $0.00 | $0.00 | $900000.00 |
| Income Before Tax | -$6.08M | -$9.78M | -$1.88M | $966000.00 |
| Income Before Tax Ratio | -$0.46 | -$1.41 | -$0.15 | $0.06 |
| Income Tax Expense | -$662000.00 | -$1.28M | -$716000.00 | -$1.14M |
| Net Income | -$5.41M | -$8.50M | -$1.16M | $2.10M |
| Net Income Ratio | -$0.41 | -$1.23 | -$0.10 | $0.13 |
| EPS | -$0.02 | -$0.03 | -$0.005 | $0.009 |
| Diluted EPS | -$0.02 | -$0.03 | -$0.005 | $0.009 |
| Weighted Avg Shares Outstanding | $348.22M | $244.06M | $240.82M | $239.32M |
| Weighted Avg Shares Outstanding (Diluted) | $348.22M | $244.06M | $240.82M | $239.32M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan